BioClinica Inc (NASDAQ:BIOC) Investor Alert: Investigation of Takeover Offer by JLL Partners, Inc
An investigation on behalf of investors in BioClinica Inc (NASDAQ:BIOC) shares was announced concerning whether the offer by JLL Partners, Inc to acquire BioClinica Inc for $7.25 per NASDAQ:BIOC share and the takeover process are unfair to investors in NASDAQ:BIOC shares.
View full press release